SCHEMBL13961680

SCHEMBL13961680

Bc1cc(C(C)O)c2ncn(COCC[Si](C)(C)C)c2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2430057 0.86 DGAT1 (0.34) —
SCHEMBL13961678 0.82 — —
SCHEMBL13961677 0.79 TSHR (0.34) —
SCHEMBL13961674 0.79 DGAT1 (0.32) —
SCHEMBL13961673 0.76 DGAT1 (0.36) —
SCHEMBL2143567 0.70 PRPS1 (0.38) —
SCHEMBL12289525 0.70 DGAT1 (0.32) —
SCHEMBL2143618 0.70 DGAT1 (0.32) —
SCHEMBL21988814 0.70 F2RL1 (0.32) —
SCHEMBL31337206 0.69 DGAT1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009009411-A1 SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-15 — — WO disclosed
Send feedback